Two of the vaccines we have for COVID-19 have the distinction of being the first mRNA vaccines to see widespread use in ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

The company, however, continues to work on a phase 1/2 study of its H5 mRNA flu vaccine for pandemic preparedness.

Why are vaccines so hard to make? The fda approved two mRNA vaccines for COVID-19, but it was a challenge to make this type of vaccine work. In fact, it took decades of research to get us to the point ...

Singling out Health Secretary Robert F. Kennedy Jr.’s worst decision is difficult, because the competition is fierce, but near the top of the list was his decision to terminate a series of federal ...

(Reuters) -Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies were twice as likely to be alive three years after beginning ...

Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.

On Sept. 4, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. is scheduled to testify before the Senate Finance Committee, where he is expected to face questions about his vaccine ...

Add Yahoo as a preferred source to see more of our stories on Google. A healthcare worker places vials containing doses of the "Comirnaty" Pfizer BioNTech and Moderna vaccines against the coronavirus ...